| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.096 | 0.1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |